Understand the source comparison
ACE-031 vs Follistatin: Comparative Research Profiles
Both ACE-031 and Follistatin inhibit myostatin and activin signalling, but through different mechanisms and with different characteristics: Molecular Type Fusion protein (80 kDa) Peptide (37-44 kDa) Target Specificity Myostatin, Activin-A Multiple TGF-β ligand
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Both ACE-031 and Follistatin inhibit myostatin and activin signalling, but through different mechanisms and with different characteristics:
- Molecular Type
- Fusion protein (80 kDa)
- Peptide (37-44 kDa)
- Target Specificity
- Myostatin, Activin-A
- Multiple TGF-β ligands
- Half-Life
- Days (Fc-mediated)
- Hours
- Systemic Effects
- Sustained
- More transient
- Production
- Mammalian cells
- Chemical/bio synthesis
- ACE-031’s extended half-life and selective targeting make it particularly suited for chronic disease models, whilst Follistatin’s broader specificity may be preferred for certain research applications.